LEADER 01475nam a2200301 u 4500
001 EB000944242
003 EBX01000000000000000737832
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 030903583X 
020 |a 9780309035835 
245 0 0 |a Assessing medical technologies  |h Elektronische Ressource  |c Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention, Institute of Medicine 
260 |a Washington, D.C.  |b National Academy Press  |c 1985, 1985 
300 |a xvii, 573 p.  |b ill 
505 0 |a Includes bibliographies and index 
653 |a Biomedical Technology / standards 
653 |a Technology Assessment, Biomedical 
653 |a Evaluation Studies as Topic 
710 2 |a Institute of Medicine (U.S.)  |b Committee for Evaluating Medical Technologies in Clinical Use 
710 2 |a Institute of Medicine (U.S.)  |b Division of Health Sciences Policy 
710 2 |a Institute of Medicine (U.S.)  |b Division of Health Promotion and Disease Prevention 
710 2 |a Henry J. Kaiser Family Foundation 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a "This study was supported by the Henry J. Kaiser Family Foundation ... [et al.]"--T.p. verso 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK217472  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 600